4/9
08:00 am
asmb
Assembly Biosciences Highlights Presentations on Positive Phase 1b Data for ABI-5366 and ABI-1179 in Recurrent Genital Herpes at ESCMID Global 2026
Low
Report
Assembly Biosciences Highlights Presentations on Positive Phase 1b Data for ABI-5366 and ABI-1179 in Recurrent Genital Herpes at ESCMID Global 2026
4/6
08:02 am
asmb
Assembly Biosciences (ASMB) had its price target raised by Guggenheim from $39.00 to $43.00. They now have a "buy" rating on the stock.
Low
Report
Assembly Biosciences (ASMB) had its price target raised by Guggenheim from $39.00 to $43.00. They now have a "buy" rating on the stock.
3/29
01:09 am
asmb
Low
Report
3/26
08:02 am
asmb
Assembly Biosciences (ASMB) had its "buy" rating reaffirmed by HC Wainwright. They now have a $50.00 price target on the stock.
Medium
Report
Assembly Biosciences (ASMB) had its "buy" rating reaffirmed by HC Wainwright. They now have a $50.00 price target on the stock.
3/19
04:55 pm
asmb
Assembly Biosciences Reports Year-End 2025 Financial Results and Recent Highlights [Yahoo! Finance]
Medium
Report
Assembly Biosciences Reports Year-End 2025 Financial Results and Recent Highlights [Yahoo! Finance]
3/19
04:38 pm
asmb
Assembly Biosciences: Q4 Earnings Snapshot [Yahoo! Finance]
Medium
Report
Assembly Biosciences: Q4 Earnings Snapshot [Yahoo! Finance]
3/19
04:32 pm
asmb
Assembly Biosciences GAAP EPS of -$0.55 beats by $3.01, revenue of $72.3M beats by $35.02M [Seeking Alpha]
Low
Report
Assembly Biosciences GAAP EPS of -$0.55 beats by $3.01, revenue of $72.3M beats by $35.02M [Seeking Alpha]
3/19
04:05 pm
asmb
Assembly Biosciences Reports Year-End 2025 Financial Results and Recent Highlights
Medium
Report
Assembly Biosciences Reports Year-End 2025 Financial Results and Recent Highlights